Executives from pharmaceutical companies including Johnson & Johnson (NYSE:JNJ), Amgen (NSDQ:AMGN), Merck (NYSE:MRK) and Eli Lilly (NYSE:LLY) met with President Donald Trump today to discuss issues ranging from drug pricing to regulatory approval for pharmaceuticals. The president called on the company execs to increase U.S. production and lower “astronomical” drug prices. Although Trump doubled down on his […]
Amgen
Amgen wins recommendation for single injection Repatha device
Amgen (NSDQ:AMGN) said today that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a positive opinion for its Repatha single monthly injection device. The device is already cleared in Europe for dosing every 2 weeks. The hands-free device, with prefilled cartridges, delivers 420 milligrams of Repatha (evolocumab) in a single injection. […]
Analyst: Insulet’s drug-delivery biz a long-term growth driver
Insulet’s (NSDQ:PODD) drug-delivery business will be a long-term growth driver for the company by as much as 20% a year for the next few years, according to Leerink Partners analysts. Billerica, Mass.-based Insulet generates 86% of its revenue from its OmniPod insulin delivery device, according to Leerink. The OmniPod technology could be easily adapted to […]
Amgen 2nd-quarter profit tops Street view, raises 2016 forecast
(Reuters) – Amgen (NSDQ:AMGN) on Wednesday reported higher-than-expected 2nd-quarter profit on increased sales of its blockbuster rheumatoid arthritis drug Enbrel and newer medicines, and the company again raised its full-year forecast. The forecast appeared to signal management’s confidence in the 2nd half of the year. The company is on track to meet or exceed its long-term objectives,” Chief […]
Amgen taps West’s SmartDose for Pushtronex system
Amgen (NSDQ:AMGN) is partnering with West Pharmaceutical Services to integrate its SmartDose delivery platform into its Pushtronex system, the companies said today. The SmartDose technology is designed to adhere to a patient’s body, generally on the abdomen, and requires no patient operation during administration, the companies said. The technology includes integrated silicone-free Daikyo Crystal Zeniths’s cartridge […]
Unilife & Amgen finalize $75m co-development deal
Unilife (NSDQ:UNIS) said today it finalized a $75 million collaborative deal with Amgen (NSDQ:AMGN) for injectable drug delivery systems, a deal the companies have been working out for the past month. The deal includes licensing, investment, development and supply agreements and is centered around Unilife’s prefilled customizable wearable injectors, according to an SEC filing from the York, […]
Unilife, Amgen extend negotiations a 3rd time
Unilife (NSDQ:UNIS) and Amgen (NSDQ:AMGN) are tacking on another 11 days to come to an agreement on whether their deal for Unilife’s wearable injector technology will be exclusive to Amgen or not. The extension makes the 3rd in the past month for the companies, as they gave themselves another week last Monday to settle the deal. Two weeks […]
Unilife, Amgen extend exclusivity negotiations again
Unilife (NSDQ:UNIS) and Amgen (NSDQ:AMGN) are giving themselves another week to come to an agreement on whether their deal for Unilife’s wearable injector technology will be exclusive to Amgen. UNIS shares jumped last month after the companies revealed the initial deal, which called for a non-refundable $15 million deposit from Amgen, which will use Unilife’s wearable injector devices for some […]
Amgen, Unilife extend talks on exclusivity deal
Unilife (NSDQ:UNIS) and Amgen (NSDQ:AMGN) are giving themselves to the end of the week to come to an agreement on whether their deal for Unilife’s wearable injector technology will be exclusive to Amgen. UNIS shares jumped last month after the companies revealed the initial deal, which called for a non-refundable $15 million deposit from Amgen, which will use Unilife’s […]
Unilife jumps on $15m Amgen injector deal
Unilife (NSDQ:UNIS) saw shares jump over 50% after signing a $15m deal with Amgen (NSDQ:AMGN) that positions the company to offer Amgen its wearable injector devices. The strategic partnership included a non-refundable $15 million deposit from Amgen, who will use Unilife’s wearable injector devices along with “certain large volume drug products”. The deal also included a perpetual […]
